Do gabapentin or pregabalin directly modulate the µ receptor?
Background Pregabalin and gabapentin improve neuropathic pain symptoms but there are emerging concerns regarding their misuse. This is more pronounced among patients with substance use disorder, particularly involving opioids. Co-ingestion of gabapentinoids with opioids is increasingly identified in...
Main Authors: | Preeti Manandhar, Bridin Patricia Murnion, Natasha L. Grimsey, Mark Connor, Marina Santiago |
---|---|
פורמט: | Article |
שפה: | English |
יצא לאור: |
PeerJ Inc.
2021-04-01
|
סדרה: | PeerJ |
נושאים: | |
גישה מקוונת: | https://peerj.com/articles/11175.pdf |
פריטים דומים
-
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
מאת: Emily J.R. Carter, et al.
יצא לאור: (2024-11-01) -
A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder
מאת: Qin Xiang Ng, et al.
יצא לאור: (2021-08-01) -
Efficacy and safety of pregabalin and gabapentin in spinal stenosis: a systematic review and meta-analysis
מאת: Telmo Martínez, et al.
יצא לאור: (2023-11-01) -
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
מאת: Payal H. Desai, PharmD, BCCCP, et al.
יצא לאור: (2021-07-01) -
Gabapentin and Pregabalin in chronic neuropathic pain: cost efficacy evaluation
מאת: Paolo Marchettini, et al.
יצא לאור: (2005-05-01)